Testosterone tablet: Began Phase III trial

Columbia Laboratories Inc. (COB), New York, N.Y. Product: Testosterone tablet Business: Metabolic Therapeutic category: Hormone replacement Target: Androgen receptors Description: Bioadhesive progres...